Global News Distribution

Medical

Susan Harding, MD, an Orthopaedic Surgeon with Penn Orthopaedics Cape May Court House

April 1, 2022 (Global News Distribution) -

Get to know Orthopaedic Surgeon Dr. Susan Harding, who serves patients in Cape May Court House, New Jersey & Philadelphia, Pennsylvania.

Board-certified and fellowship-trained orthopaedic surgeon, Dr. Harding, specializes in hand injuries and pediatric trauma. She is affiliated with Penn Medicine, offering her services at Penn Orthopaedics Cape May Court House in New Jersey.

Likewise, she is a part of the Penn Orthopaedic Trauma and Fracture program. It is the largest and most complete program in the Philadelphia region, with extensive capabilities for treating all musculoskeletal fractures, traumatic injuries, and related complications.

Prior to joining Cape Regional Physicians Associates and Cape Regional Health System, she served as the Associate Program Director, Clinical Service Chief, as well as Director of Orthopaedic Trauma within the Department of Orthopaedic Surgery at Hahnemann University Hospital.

At the start of her academic career, Dr. Harding earned her medical degree from Drexel University College of Medicine in 1991. She then went on to complete her internship in general surgery and her residency in orthopaedic surgery at Hahnemann University Hospital. This was followed by a fellowship in orthopaedic trauma at Harborview Medical Center in Seattle, Washington. 

A member of the Pennsylvania Orthopaedic Society and the American Academy of Orthopaedic Surgeons, the doctor is board-certified in orthopaedic surgery by the American Board of Orthopaedic Surgery (ABOS). The ABOS is an organization with the goal of establishing educational and professional standards for orthopaedic residents and surgeons, as well as evaluating the qualifications and competence of orthopaedic surgeons. 

Professionally, Dr. Harding holds privileges at the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Pennsylvania Hospital, and Penn Musculoskeletal Center – University City, 7th Floor.

Alongside her clinical role, she serves as an Associate Professor in the Department of Orthopaedic Surgery at Drexel University College of Medicine in Philadelphia, Pennsylvania.

Orthopaedic surgery is the branch of surgery concerned with conditions involving the musculoskeletal system. Orthopaedic surgeons use both surgical and non-surgical means to treat musculoskeletal trauma, spine diseases, sports injuries, degenerative diseases, infections, tumors, and congenital disorders.

For her vast clinical expertise, Dr. Harding was recognized and named a “Top Doctor” by Philadelphia Magazine in 2018. 

Learn More about Dr. Susan Harding:

Through her findatopdoc profile, https://www.findatopdoc.com/doctor/1801045-Susan-Harding-Orthopedist, or through Penn Medicine, https://www.pennmedicine.org/providers/profile/susan-harding 

About FindaTopDoc.com

FindaTopDoc is a digital health information company that helps connect patients with local physicians and specialists who accept your insurance. Our goal is to help guide you on your journey towards optimal health by providing you with the know-how to make informed decisions for you and your family. 

Media Contact

Your Health Contact

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Key Entrepreneurs to Present at 2022 Bioelectronic Medicine Forum

March 28, 2022 (Global News Distribution) -

Neurotech Reports, the publisher of the Neurotech Business Report and BioElectRx Business Report newsletters, announced that founders and CEOs of several promising bioelectronic medicine startups will present at the Fifth Annual Bioelectric Medicine Forum on April 5, 2022. The event will take place in New York City, although participation via Zoom videoconference will be accommodated.

Entrepreneur presenters at the conference include Attila Borbath, CEO of Synergia Medical, a European firm developing an optical vagus nerve stimulation system, Nicolas Vachicouras, CEO of Neurosoft Bioelectronics, Jennifer Ernst, CEO of Tivic Health, Manfred Franke, CEO of Neuronoff Inc., and Anuj Bhardwaj, CEO of SecondWave Systems Inc.

Peter Staats, a bioelectronic medicine pioneer and co-founder and chief medical officer of electroCore Medical, will keynote the conference. Dr. Staats is internationally recognized for his work in developing and implementing minimally invasive procedures for a number of disorders, including COVID, and his patents have led to the use of novel pharmacologic agents. He is a past President of the North American Neuromodulation Society, American Society of Interventional Pain Physicians, New Jersey Society of Interventional Pain Physicians, and the Southern Pain Society.

Other speakers at the 2022 event include Marom Biksom, professor of biomedical engineering at City College of New York, Imran Eba, partner at Action Potential Venture Capital, Chihiro Hosoya, head of venture management and business development at Astellas Pharma, Eric Hudak, program director at the National Institutes of Health, and Hannah Claridge from TTP plc in the U.K.

Other sessions will cover a range of technologies and indications for bioelectronic medicine, including applications in cardiovascular medicine, inflammation, gastrointestinal disorders, and many other clinical specialties.

MST is the Platinum Sponsor of this year’s event, while Valtronic is the Silver Sponsor.

Key topics will include promising new indications, alliances with bio/pharm firms, regulatory and reimbursement issues, and pricing/commercialization issues.

“Bioelectronic medicine is one of the most promising new segments of the healthcare industry,” said James Cavuoto, editor and publisher at Neurotech Reports. “This fifth-annual conference will be a key meeting place for entrepreneurs and executives helping to found this industry.”

For more information on the 2022 Bioelectronic Medicine Forum, contact Neurotech Reports at 415 546 1259 or visit this link: https://neurotechreports.com/pages/bioelectronic-medicine-forum.html

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Educational Children’s Book Guides Families to Live a Healthier Life

March 28, 2022 (Global News Distribution) -

Dietitian and teacher illustrate positive food values and the basics of English in ‘Queen Bee’s Alphabet Cookbook’

Introducing a healthy lifestyle at a young age is essential. In Mariah Ecker, RD, and Teri Ecker’s debut book, “Queen Bee’s Alphabet Cookbook: A Nutrition Guide for Families,” the authors provide years of experience in health and education to build a roadmap for parents to teach their children the importance of healthy habits to help them thrive.

“Queen Bee’s Alphabet Cookbook” is a guide for providing quality family time, while engaging in activities that teach important life skills, from kitchen tool safety and building healthy recipes, to offering fun ways to imprint positive food values. Children will learn early English skills and vocabulary throughout the book, with activities that progress with the child.

Peppered throughout the pages is the authors’ professional experience and insight into balancing nutrition with mindful eating, as a professional dietician and an internationally certified English teacher. From learning the ABCs to Butternut Squash Mac and Cheese and Zoodle Soup, the Eckers believe in a holistic approach to growth and development in children, as well as the community.

“We published ‘Queen Bee’s Alphabet Cookbook’ to give back,” said Teri Ecker. “We donate books as well as a percentage of profits to nonprofit organizations. We want to help families see that nutrition can be more than healthful – it can be fun! We are able to help community literacy and nutrition programs, by teaching early language skills while providing fun activities that promote a healthy foundation.”

“Queen Bee’s Alphabet Cookbook” will take families on a journey of learning about food and healthy living. Children will follow their friend, Queen Bee, as she teaches them the importance of practicing good habits, while spending quality time with loved ones.

“Queen Bee’s Alphabet Cookbook: A Nutrition Guide for Families”
By Mariah Ecker, RD and Teri Ecker
ISBN: 978-1-6657-0890-6 (softcover); 978-1-6657-0888-3 (hardcover); 978-1-6657-0889-0 (eBook)
Available at Archway Publishing, Amazon and Barnes & Noble

About the author
Mariah Ecker, RD, is a dietitian with a thriving private practice that guides families in balancing the science of nutrition with mindful eating. Teri Ecker is an internationally certified teacher of English skills with decades of teaching experience. Together, their passion for literacy and nutrition, has created an educational nutrition guide for families. Their goal is to help community food and literacy programs while making family time, leading to smarter, healthier and happier children and families. To learn more, please visit http://www.queenbeelearning.com/.

General Inquiries:            
LAVIDGE                        
Lindsey Gobel
lgobel@Lavidge.com | 480-998-2600

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Medical Device Additive Manufacturing Market to exceed US$ 4,440.5 million by 2027 says, The Insight Partners

March 24, 2022 (Global News Distribution) -

Medical Device Additive Manufacturing Market for Laser Sintering to Grow at Highest CAGR during 2020–2027

According to The Insight Partners new market research study on “Medical Device Additive Manufacturing Market to 2027 – COVID-19 Impact and Global Analysis– by Technology, Product, and Application,” the market is expected to reach US$ 4,440.5 million by 2027 from US$ 1,350.4 million in 2019; it is estimated to grow at a CAGR of 16.2% from 2020 to 2027. Factors such increasing demand for additive manufacturing in healthcare, and rising incidence of musculoskeletal and dental diseases are expected to boost the growth of the global medical device additive manufacturing market. However, the market is limited by exorbitant costs of automated medical device additive manufacturing during the forecast period.

Additive manufacturing is a technique used for manufacturing rapid prototypes as well as functional parts. The use of additive manufacturing in the medical industry has increased in the recent years owing to technological advancements. With the rising adoption of additive manufacturing in the healthcare sector, the scope for customization and innovation of medical devices has increased considerably over the last few years.

Download sample PDF Copy of Medical Device Additive Manufacturing Market study at: https://www.theinsightpartners.com/sample/TIPHE100000975/

3D Systems, Inc., GE Additives,Materialise NV, 3T Additive Manufacturing Limited, Renishawplc, Stratasys Ltd, Vaupell, Inc.,Precision ADM Inc, EOS GmbH, and Allevi, Inc. are among the leading companies operating in the medical device additive manufacturing market.

The COVID-19 outbreak was first reported in December 2019 in Wuhan (China), and with its spread to ~100 countries across the world, the World Health Organization (WHO) termed it a pandemic with public health emergency. In North America, the US has been profoundly affected by the outbreak. For instance, California-based Airwolf3D Company has proposed its fleet of 3D printers for the manufacturing of respirator valves and custom medical components. The company is also contributing remote technical support for medical staff that would be willing to know more about 3D printing. The use of 3D printing and additive manufacturing for the development of medical supplies and instruments in emergency is likely to be a prime opportunity for the market players.

Based on technology, the medical device additive manufacturing market is segmented into laser sintering, stereolithography, electron beam melting, and extrusion. In 2019, the laser-sintering segment accounted for the highest share of the market. The market growth of this segment is attributed to the fact that there is no need to provide support structures for fragile and thin parts of devices, unlike the devices produced with the use of stereolithography. Further, high precision in geometries achieved by laser sintering is not possible with any other technology; thus, the market for this segment is expected to grow at the highest CAGR during the 2020–2027.

Inquiry for Discount on Medical Device Additive Manufacturing Market at: https://www.theinsightpartners.com/discount/TIPHE100000975/?utm_source=EinPressWire&utm_medium=10144

The healthcare sector has been witnessing rapid transformation since the last few years. Various technological advancements in the sector include the customization of medical devices, use of computing technologies to design medical devices, and restructuring the core build-up of these devices through technologies such as CAD-CAM and 3D printing. With a need for better healthcare facilities, technology-enabled care (TEC) solutions are being preferred in the healthcare systems in the emerging economies. The increase in elderly population, rise in incidence of chronic illnesses, and escalating need for pediatric care are the primary factors driving the growth of healthcare sector. Various established players in this sector have been investing significant amounts of their revenue in research and development activities for the development of better and advanced products as well as technologies. Also, the availability of reimbursement for various medical procedures is contributing to the growth of the sector.

Medical device companies in the world are investing in the expansion of their capabilities and operations. Leading market players such as Medtronic; Stryker; BD; and Baxter International, Inc. are investing significant percentage of their annual incomes in the development of their manufacturing capabilities by incorporating advanced technologies such as additive manufacturing in the overall processes. Thus, the potential advancements in the global healthcare sector provide significant opportunities to the medical device additive manufacturing market players to secure growth during the forecast period.

Additive manufacturing (AM), also known as 3D printing, holds great potential to transform the conventional process of manufacturing of medical products and components. Additive manufacturing allows companies to provide extensive customization based on the individual patient requirements for medical applications. This helps save time and efforts by allowing the manufacturing of medical devices and implants that are ideal fit for patient’s needs. The technique helps overcome the constraints of traditional manufacturing methods—mainly associated with the mass customization; fabrication; milling, casting, and forging; and so on.

Interested in Purchasing Medical Device Additive Manufacturing Market Report? Click here @ https://www.theinsightpartners.com/buy/TIPHE100000975/

Browse similar report and Get sample PDF Copy

Additive Manufacturing Market to 2027 – Global Analysis and Forecasts by Material (Plastic, Metal, and Ceramics); Technology (Selective Laser Sintering (SLS), Stereolithography (SLA), and Fused Deposition Modeling (FDM)); and End-User (Automotive, Aerospace, Healthcare, and Industrial Manufacturing)
https://www.theinsightpartners.com/sample/TIPTE100001350/?utm_source=EinPressWire&utm_medium=10144

Metal Powder for Additive Manufacturing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Type (Powder Bed, Blown Powder, Others); Material (Alloy, Stainless Steel, Others); Application (3D Printing, Rapid Prototyping, Direct Digital Manufacturing (DDM)) and Geography
https://www.theinsightpartners.com/sample/TIPRE00021797/?utm_source=EinPressWire&utm_medium=10144

Aerospace Additive Manufacturing Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Material (Metal, Plastic, Rubber, Others); Technology (3D Printing, Laser Sintering, Stereolithography, Others); Application (Engine, Airframe); Platform (Aircraft, Unmanned Aerial Vehicle) and Geography
https://www.theinsightpartners.com/sample/TIPRE00007401/?utm_source=EinPressWire&utm_medium=10144

Sameer Joshi
The Insight Partners
+91 96661 11581
Visit us on social media:
Facebook
Twitter
LinkedIn

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

DS Dental Care Expands Services to Davie, FL

March 23, 2022 (Global News Distribution) -

DS Dental Care is pleased to announce they have recently opened an office to expand their reach and help more patients experience the dental care they deserve.

DS Dental Care is pleased to announce they have recently opened a second office to expand their reach and help more patients experience the dental care they deserve. The new office is located at 2879 S. University Drive in Davie, Florida.

Patients can count on DS Dental Care to provide optimal dental care for the whole family, with gentle care and experienced dentists who use the best treatments and the latest technology. The family-owned dental practice opened their second location to ensure they can give more individuals the healthy, beautiful smiles they deserve, with personalized treatment plans that address any dental concerns and provide a solid foundation for optimal dental health.

DS Dental Care is open six days a week, with emergency appointments available on Sundays. These hours ensure their patients always have access to the dental care they need, whether that’s routine cleanings and x-rays or more extensive treatments, including emergency care. With affordable pricing at 30 percent below the average for the dental industry and convenient financing options, quality dental care is more affordable and accessible than ever.

Anyone interested in learning about the new office or the dental services offered can find out more by visiting the DS Dental Care website or calling 1-954-890-2879.

About DS Dental Care: DS Dental Care is a family-owned dental clinic offering the latest treatment options with state-of-the-art equipment and affordable pricing to ensure everyone can get the healthy, beautiful smile they deserve. Their experienced team offers personalized treatment plans for each patient in a comfortable environment. Patients can count on the dental clinic to provide convenient scheduling six days a week, with same-day emergency appointments available.

Company: DS Dental Care
Address: 2879 S. University Drive
City: Davie
State: FL
Zipcode: 33328
Telephone number: 1-954-890-2879

Dania Santana, D.M.D
DS Dental Care
+1 954-890-2879
office@dsdentalcarefl.com
Visit us on social media:
Facebook
Other

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Therapeutic Transparency Essential to Solving America’s Rising Rx Expenses

March 8, 2022 (Global News Distribution) -

U.S. prescription drug prices, the highest in the world, are particularly problematic for minorities and people of color, says Paul Ford, Founder and President of DS9 Capital. One possible solution is greater pricing and therapeutic transparency.

A new report from the Rand Corporation shows that prescription drug prices in the United States, particularly for brand-name drugs, are more than twice as high as in other countries. In the 32 nations surveyed in the report, the US accounted for 58% of the total spend, but only 24% of the consumption.(1) While elevated US drug prices affect everyone in the country, notes Paul Ford, founder and president of DS9 Capital, they particularly disadvantage people of color and other minorities. “Approximately 60% of Americans are on medication,” says Ford. “There are people making $90,000 a year who have difficulties paying for medicine. How can lesser-paid people cope? And it’s worse for the under- and uninsured.”

Faced with an unmanageably expensive prescription, Ford observes, some patients simply do without the medicine, while others resort to cutting pills in half or skipping doses. It doesn’t, he adds, look as though the situation will improve anytime soon. In recent years, 41 drugs increased more than 100% in price in the US, including the widely used antidepressant Prozac, which went up 879%.(2)

There are, says Ford, a number of factors contributing to high US prescription prices:

  • Lack of regulation. While the Food and Drug Administration regulates how drugs are tested, marketed, and released for sale, it has no control over price.
  • Exclusivity protection. When a new drug hits the market. It is immediately placed under patent and drug exclusivity.
  • Price hikes in the supply chain. The actions of insurance companies and pharmacy benefit managers can have a significant effect on drug prices.
  • Administrative costs.
  • Limited market competition.(3)

Faced with escalating drug costs, many Americans turn to prescription discount cards. With the card, they may pay significantly less for certain prescriptions. The consumer does not pay for the card. Rather, discount card services make their money by charging the participating pharmacies and supermarkets in their network a small fee for each transaction.(4) Physicians, notes Ford, tend to be unaware of drug costs and lack the realization of the large difference in cost between inexpensive and expensive drugs.(5)

Meanwhile, the Biden administration has announced a prescription drug pricing plan as part of its Build Back Better initiative. The plan, as announced, will:

  • Allow Medicare to negotiate drug prices.
  • Impose a tax penalty if drug companies increase their prices faster than inflation.
  • Directly lower out-of-pocket drug costs for seniors.(6)

What is needed, says Ford, is a sort of clearinghouse for information that acts as a transparent interface between the consumers of pharmaceutical products (i.e., patients and their providers: pharmaceutical manufacturers, digital therapeutics, and bio sciences companies). Working through a network of retail and independent pharmacies, it would deliver a personalized approach to healthcare providing lower cost treatment alternatives, evaluating pricing and therapeutic alternatives that do not sacrifice drug effectiveness and cost less.

There is, in fact, such an organization, says Ford. OrchestraRx is a LegitScript Certified prescription drug management and data company founded on inclusion, healthy outcomes, consumerism, and technology. While it functions as a personalized health treatment optimizer, it does not own any pharmacies.(7)

This, says Ford, is the future for pharma. “The fact that a private organization has stepped up and provided this service,” he says, “is a very encouraging, and very ambitious with results. It’s a case of a visionary business understanding what needs to be done and—without trying to corner or manipulate any part of the market, works within the existing market to optimize outcomes dynamically.”

About DS9 Capital:
DS9 Capital is a founder-friendly portfolio management holding company focused on building enduring and stable cash-flowing businesses in the insurance and healthcare technology space. DS9 is generally focused on frontier technology and service offerings in the insurance and healthcare space largely leveraging cloud-based infrastructure, and more specifically on applying our domain expertise to nano-cap sized businesses to expand the value chain for all stakeholders. This value creation typically includes investment, leveraging our vast resources and networks to create a strategic pipeline for organic growth and realigning the businesses to optimize commercial and IP assets. Our tactical goal with each of our companies is to leverage our expertise into higher margin and missed revenue opportunities.

1. Curley, Christopher. “U.S. Prescription Drug Prices Are Twice as High.” Healthline, 3 Feb. 2021, healthline.com/health-news/prescription-drug-prices-in-the-u-s-are-twice-as-high-heres-why.
2. Frakt, Austin, Benavidez, Gilbert. “Racial Disparities, Prescription Medications, and Promoting Equity.” Public Health Post, 21 Aug. 2018, publichealthpost.org/viewpoints/racial-disparities-prescription-medications-equity/.
3. “Why Are Prescription Drugs More Expensive in the U.S. than in Other Countries?” GoodRx, goodrx.com/healthcare-access/drug-cost-and-savings/why-are-prescription-drugs-more-expensive-in-the-us-than-in-other-countries.
4. “Discount Drug Cards Promise Huge Savings on Your Prescriptions. but Is There a Catch?” Money, money.com/discount-drug-cards-promise-huge-savings-on-your-prescriptions-but-is-there-a-catch/.
5. “Physician Awareness of Drug Cost: A Systematic Review.” PLoS Medicine, U.S. National Library of Medicine, pubmed.ncbi.nlm.nih.gov/17896856/.
6. “Digital Patient Acquisition Platform.” OrchestraRx, orchestrarx.com/.
7. “President Biden Announces Prescription Drug Pricing Plan in Build Back Better Framework.” The White House, The United States Government, 2 Nov. 2021, whitehouse.gov/briefing-room/statements-releases/2021/11/02/president-biden-announces-prescription-drug-pricing-plan-in-build-back-better-framework/.

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Wildflower Health Announces $26 Million Financing Round to Support National Expansion of Value-Based Maternity Care Offerings

March 8, 2022 (Global News Distribution) -

Company will use funding to scale its unique approach to value-based care within the maternity setting while driving further innovation within the women’s health space

Wildflower Health, a women’s health solutions company specializing in digital and value-based care, today announced the close of a new financing round of $26 million. The round was led by TT Capital Partners with participation from existing investors, including Providence Ventures, Health Enterprise Partners, Hatteras Venture Partners, and Echo Health Ventures.

“Despite increased venture investments in women’s health, providers and payers have struggled to advance true value-based care with OB providers,” said Dawn Owens, CEO and Partner of TT Capital Partners, who will join Wildflower’s Board as part of the investment. “Wildflower is the first company in the market to fill the solution gaps that have prevented widespread adoption of value-based care in women’s health. Wildflower is ushering in a new era, and we are proud to be part of it.”

In addition to increasing its financial commitment in Wildflower, Providence also has expanded its contract with Wildflower to include installation of Wildflower’s solution for value-based maternity care across its Southern California region. The health system will work with Wildflower to engage health plans and employers to drive successful and sustainable value-based care and payment models in obstetric and newborn care.

“Wildflower has been an extremely valuable partner, helping drive patient and provider activation in digital health technologies to improve quality of care across our health system,” said Dr. David Lagrew, executive medical director of women’s services for Providence. “We are excited to fully leverage the company’s expertise in value-based maternity care to transform the way we care for mothers and babies. Wildflower’s technology and health advocacy services, combined with a leading set of value-based consulting and modeling capabilities is unique. With this support, we can bring all stakeholders together and deliver something very special for our patients, our providers and our community.”

Wildflower will leverage the financing round to strengthen its internal team and prepare for the nationwide expansion of a proprietary maternity bundle that fully operationalizes value-based care for OB providers. Wildflower’s solution helps providers evaluate and design VBC models alongside payers; install both digital health and point-of-care decision support tools; adapt current workflows to value-based requirements and continuously process data, both for leveraging key clinical metrics in real-time, as well as managing financial payments, reconciliations and outcomes measurement.

Wildflower’s maternity bundle is comprehensive, spanning from prenatal to postnatal care and accounts for the total cost of pregnancy for both mom and baby. The company ensures providers are rewarded based on the best clinical care and cost containment methodologies.

With the Wildflower solution, providers and payers gain the power to view pricing and quality improvement opportunities, understand specific metrics, and project potential savings available for maternity and newborn episodes. The solution also fully enables financial management of the bundle, including distribution of payments to all participating providers, based on performance. From initial discussions to implementation, providers and payers have a blueprint to follow.

“We have been committed to transforming patient care and outcomes in women’s health from the beginning,” said Leah Sparks, founder and CEO of Wildflower Health. “The next phase of delivering on that mission requires accelerating the transition from fee-for-service to a model that rewards providers based on quality outcomes. We are excited to embark on this next chapter in partnership with our payer and provider clients.”

Wildflower was founded in 2012 as a mobile health company to help women have healthy pregnancies. Over time, the company expanded its capabilities to support the evolving health journey for families across all life stages. Today, Wildflower supports the entire ecosystem – the provider, the payer, the family – with a solution that is purpose-built to advance more effective, equitable care, as well as the payment models that fuel it.

Wildflower has received multiple accolades for its work in the women’s health space, including being recognized as “Best Femtech Company” by the University of San Francisco’s Digital Health Awards. The company received the Validation Institute’s Health Value Award for maternity management and has been featured as an innovator at TedMed and as a speaker at SXSW, HLTH, Rock Health Summit and the World Health Care Congress.

About Wildflower
Wildflower is a women’s health solutions company, specializing in digital and value-based care. We are the architect of the industry’s first, and only, comprehensive bundle for value-based maternity care, with pre-built functionality for all actuarial, clinical and operational needs. Wildflower is facilitating the transition to value, starting with the OB episode.

Our capabilities include a combination of technology, health advocacy and value enablement services, all designed to simplify the journey to value-based care for providers, payers, and purchasers by collapsing silos and aligning rewards around the delivery of healthy outcomes for women and their families. Wildflower is ushering in a new era for women’s health. This is a smarter way to care. http://www.wildflowerhealth.com

Contact Author

JESSICA SZALAY

Wildflower Health
408-780-8983

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Recognize Red Flags for Your Heart Health

March 7, 2022 (Global News Distribution) -

(Family Features) A red flag is a common signal indicating potential danger or trouble, and that includes issues related to your health.

An educational campaign sponsored by Amarin Pharma Inc. encourages patients who have had a heart attack or stroke to “Raise a Red Flag” with their health care providers to learn more about their increased risk of another serious cardiovascular event.

Consider this information to help protect your heart health by understanding more about possible risk factors and how to reduce them.

Red Flags for Increased Risk

According to the American Heart Association, every 40 seconds someone in the U.S. has a heart attack or stroke. Research shows people who have had a heart attack are up to 50% more likely to have another cardiovascular event or heart procedure within a year.

In addition to having a medical history that includes heart disease or other heart-related incidents, like heart attack or stroke, there are other red flags that indicate you may be at increased risk for another cardiovascular event.

Other risk factors may be beyond your control, but awareness may help you manage your risk. A family history of heart disease puts you at greater risk, as does increasing age and other health conditions and lifestyle choices.

Reduce Your Risk

While you can’t control your age or genetics, you can make lifestyle adjustments and explore medications and other ways to manage your heart health, especially if you’ve already experienced heart health problems.

“Treating heart disease and stroke is a partnership and each individual’s doctor and health care team will develop a treatment plan that’s right for that patient,” said cardiologist Dr. John Isaac, an Amarin consultant. “For my patients who have already had a cardiovascular event, such as a heart attack or stroke, I often prescribe VASCEPA® (icosapent ethyl) to reduce the risk of another life-threatening cardiovascular event.”

The medication is used along with certain medicines (statins) to reduce the risk of heart attack, stroke and certain types of heart issues requiring hospitalization in adults with cardiovascular disease or diabetes and two or more additional risk factors for heart disease. It is not known if it is safe and effective in children.

In a clinical study, patients treated with VASCEPA had fewer cardiovascular events (17.2%) compared to those who took placebo (22%). Itis the only FDA-approved prescription oral medication clinically proven to reduce cardiovascular risk by up to 25% when taken along with certain medicines, such as statins.

You shouldn’t take VASCEPA if you’re allergic to icosapent ethyl or any inactive ingredient in the medication. Stop taking it and seek medical help if you have symptoms of an allergic reaction. Serious side effects may occur like heart rhythm problems and bleeding. Tell your doctor if you experience an irregular heartbeat or other heart rhythm problems. Other possible side effects include muscle and joint pain.

For more information, including Prescribing Information, Patient Information, Indications, Limitations of Use and Important Safety Information, visit raisearedflag.comto get your questions answered and schedule a health care provider appointment either in-person or via a telehealth visit.

Photo courtesy of Adobe Stock

IMPORTANT SAFETY INFORMATION

WHO SHOULD NOT TAKE VASCEPA?

  • Do not take VASCEPA if you are allergic to icosapent ethyl or any of the ingredients in VASCEPA.

WHAT ARE THE POSSIBLE SIDE EFFECTS OF VASCEPA?
VASCEPA may cause serious side effects, including:

  • Heart rhythm problems (atrial fibrillation and atrial flutter).

Heart rhythm problems which can be serious and cause hospitalization have happened in people who take VASCEPA, especially in people who have heart (cardiovascular) disease or diabetes with a risk factor for heart (cardiovascular) disease, or who have had heart rhythm problems in the past. Tell your doctor if you get any symptoms of heart rhythm problems such as feeling as if your heart is beating fast and irregular, lightheadedness, dizziness, shortness of breath, chest discomfort or you faint.

  • Possible allergic reactions if you are allergic to fish or shellfish.

Stop taking VASCEPA and tell your doctor right away or get emergency medical help if you have any signs or symptoms of an allergic reaction.

  • Bleeding.

Serious bleeding can happen in people who take VASCEPA. Your risk of bleeding may increase if you are also taking a blood thinner medicine.

If you have liver problems and are taking VASCEPA, your doctor should do blood tests during treatment.

The most common side effects of VASCEPA include:

  • Muscle and joint pain
  • Swelling of the hands, legs, or feet
  • Constipation
  • Gout
  • Heart rhythm problems (atrial fibrillation)

These are not all the possible side effects of VASCEPA. Call your doctor for medical advice about side effects. You may report adverse events (i.e. side effects) or product complaints by contacting AmarinConnect at 1-855-VASCEPA (1-855-827-2372), emailing AmarinConnect@Amarincorp.com, or calling the FDA at 1-800-FDA-1088.

Tell your doctor if you take medicines that affect your blood clotting (anticoagulants or blood thinners).

For more information on VASCEPA, click here to see the full Patient Information or call 1-855-VASCEPA (1-855-827-2372).

Michael French
mfrench@familyfeatures.com
1-888-824-3337
editors.familyfeatures.com

About Family Features Editorial Syndicate

A leading source for high-quality food, lifestyle and home and garden content, Family Features provides readers with topically and seasonally relevant tips, takeaways, information, recipes, videos, infographics and more. Find additional articles and information at

Culinary.net

and

eLivingToday.com

SOURCE: Family Features

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

Kajeet to Discuss Digital Healthcare Equity at HIMSS 2022

March 3, 2022 (Global News Distribution) -

Kajeet’s chief technology officer, Greg Jones, will host a session on digital inequities in healthcare and participate in a social determinants of health panel discussion at the annual conference

WHAT
The COVID-19 pandemic and overburdened healthcare industry have rendered digital healthcare connectivity a necessity – and yet, 19 million Americans remain without reliable internet access in their homes. There is a crucial need to address digital inequity for patients unable to visit traditional healthcare settings – including the most vulnerable, elderly and disadvantaged populations – and deliver secure, cost-effective connectivity solutions while improving medical outcomes.

At the 2022 HIMSS Global Health Conference & Exhibition, Kajeet chief technology officer, Greg Jones, will present a 20-minute session titled “Delivering Equitable Digital Healthcare Solutions.” In this session, he will discuss the importance of equitable digital healthcare solutions, how the COVID-19 pandemic has shone a spotlight on the problems burdening our healthcare system and a path to solving these issues.

Additionally, Kajeet is participating in the Social Determinants of Health (SDOH) “Sip & Learn” Advancing Equitable Interoperability event. Curated by the HIMSS SDOH Task Force, a panel of experts will discuss equitable interoperability concerning sensitive data sharing, health equity and accessibility.

WHO
Greg Jones, chief technology officer, Kajeet
Greg leads Kajeet’s technology strategy, product development and innovation. Prior to Kajeet, Greg was the CIO, Global Products and Services at Laureate Education, the world’s largest higher education company. Prior to Laureate, he served as the CTO for Inovalon, an industry leader in healthcare information technology, and previously as the vice president of Enterprise Applications at Sprint Nextel. Greg earned his bachelor’s degree in information systems from James Madison University and his master’s degree in management information systems from American University. Greg has significant international experience, having worked in over 20 countries. He also lived in Spain for three years, where he became fluent in Spanish.

WHEN & WHERE
Greg’s session will be held:
Date: Tuesday, Mar. 15, 2022
Time: 4:45 p.m. – 5:05 p.m. ET
Location: Consumerism/Patient Engagement Pavilion, Orange County Convention Center, 9899 International Drive, Orlando FL 32819; Expo Booth 5080

Sip and Learn will be held:
Date: Wednesday, Mar. 16, 2022
Time: 5:30 p.m. – 6:30 p.m. ET
Location: Interoperability Showcase, Expo Booth 8240

Register at: https://www.himss.org/global-conference/session-social-determinants-health-sip-learn-advancing-equitable-interoperability

About Kajeet
Kajeet is a leading managed IoT connectivity service provider and a trusted leader in education, providing software and hardware solutions that deliver safe, reliable, and controlled internet connectivity to nearly 3,000 businesses, schools and districts, state, and local governments, and IoT solution providers.

Kajeet holds 40 U.S. patents in mobile technologies. To learn more, http://www.kajeet.net and follow us on Twitter at @Kajeet.

Contact Author

ELIZABETH BUCCIANTI

Gabriel Marketing Group (for Kajeet)
407-463-8865

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection

OXOS Medical Scores US Patent for Rolling Collimator, Opening Access to Micro C X-ray Imaging System

March 3, 2022 (Global News Distribution) -

New OXOS patent for rolling collimator x-ray technology simplifies execution and reduces reshoots and radiation exposure for distal extremity x-ray imaging

OXOS Medical, the radiographic imaging company creating point of care x-ray diagnostics, has announced the award of a US patent for an innovative, rolling collimator, making Micro C even easier to use. The patent details advanced collimator mechanisms, vital to x-ray imaging, eliminating the need to readjust the positioning of the x-ray emitter and detector for handheld and portable systems. This invention is crucial to simplifying the diagnostic processes.

“My surgeon colleagues and I found traditional imaging systems cumbersome, whereas the portables produced poor quality [x-ray] images,” said Gregory Kolovich, MD CEO and Founder OXOS Medical Inc. “At OXOS, we developed a ‘rolling collimator’ to keep the x-ray field in the best orientation. This patent issuance recognizes the novel and unique approach we took to make better imaging systems.”

The OXOS rolling collimator autonomously optimizes the emission field size based on the emitter’s positioning in three-dimensional space. The novel self-adjusting component of the collimator reorientates the emission field by leveraging the sensor array system and associated OXOS position tracking system. The coupling of these systems contributes to maintaining the ALARA (As Low As Reasonably Achievable) principle when assessing potential radiation exposure for the patient and user. This advancement in radiographic technology is valuable to those looking to decrease reshoots and excessive adjustments to minimize radiation exposure and obtain the best x-ray image for clinical decision-making.

“The active collimator is one of the most innovative features in Micro C and a critical part of clinical workflow. The machine handles safety, allowing me to concentrate on the patient,” says Dr. Elliot Robinson of OrthoGeorgia.

OXOS looks to continue producing impactful, innovative solutions that are the best at addressing key pain points in medical imaging. CEO Evan Ruff notes, “OXOS’ goal is to create the safest, smartest, most easy to use x-ray instrument possible. Adding this patent to our growing portfolio demonstrates our commitment to making radiographic imaging accessible to anyone, anywhere.”

To learn more about OXOS Medical and its product portfolio, schedule an in-person or a virtual demo by visiting the company website https://oxos.com/contact/. Stay up to date with OXOS via LinkedIn, Instagram, and Twitter.

About OXOS™ Medical
OXOS™ Medical puts the future of X-ray in your hands. OXOS Micro CⓇ, the first handheld Dynamic Digital Radiographic X-ray system, is faster, safer, and smarter than conventional x-ray solutions and has received U.S. Food and Drug Administration 510k clearance for radiographic imaging and DDR of the distal extremity in adults and children. Micro C brings radiologic diagnosis to the point of care with a handheld X-ray that delivers medical imaging with clarity and accuracy while operating safely without a radiation suite in most cases. The cloud-based OXOS™ Platform offers growing capabilities for on-demand image management, telehealth collaboration, and delivery of AI diagnostics. Additional information at https://oxos.com/ or email info@oxos.com.

Josslyn Lally
OXOS Medical, Inc.
josslyn.lally@oxos.com

Media Contacts:


Full Name
Company
Phone Number
Website
Email

Compose your email to at .


  Spam Protection